Scinai Immunotherapeutics annual shares outstanding
2021
2022
2023
2024
2025
Scinai Immunotherapeutics Shares Outstanding History (SCNI)
Scinai Immunotherapeutics reported 13.87B shares outstanding at the end of fiscal 2025.
View full Scinai Immunotherapeutics company overviewScinai Immunotherapeutics annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 13.87B | 10.46B | +306.59% |
| 2024 | 2024-12-31 | 3.41B | 1.55B | +83.72% |
| 2023 | 2023-12-31 | 1.86B | 867.9M | +87.73% |
| 2022 | 2022-12-31 | 989.3M | 250.2M | +33.86% |
| 2021 | 2021-12-31 | 739.0M | — | — |
Scinai Immunotherapeutics quarterly shares outstanding
Q4.21
Q4.22
Q1.23
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 13.87B | 12.02B | +646.99% |
| Q2 2025 | 2025-06-30 | 6.06B | 4.60B | +316.56% |
| Q4 2024 | 2024-12-31 | 3.41B | 2.10B | +159.74% |
| Q2 2024 | 2024-06-30 | 3.35B | 2.36B | +238.57% |
| Q4 2023 | 2023-12-31 | 1.86B | 1.12B | +151.29% |
| Q2 2023 | 2023-06-30 | 1.45B | — | — |
| Q1 2023 | 2023-03-31 | 1.31B | — | — |
| Q4 2022 | 2022-12-31 | 989.3M | — | — |
| Q4 2021 | 2021-12-31 | 739.0M | — | — |
Scinai Immunotherapeutics shares outstanding trends
Across the available reported history, Scinai Immunotherapeutics's shares outstanding moved from 3.41B to 13.87B, a change of 10.46B. The latest reported quarter, Q4 2025, shows 13.87B.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Scinai Immunotherapeutics filings at SEC.gov ↗